Symbols / BFRI Stock $1.12 -0.88% Biofrontera Inc.

Healthcare • Drug Manufacturers - Specialty & Generic • United States • NCM
BFRI (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Dr. Hermann Luebbert Ph.D.
Exch · Country NCM · United States
Market Cap 13.05M
Enterprise Value 12.81M
Income -10.54M
Sales 41.70M
FCF (ttm) -2.36M
Book/sh 0.90
Cash/sh 0.55
Employees 84
Insider 10d
IPO Oct 29, 2021
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E
Forward P/E -4.87
PEG
P/S 0.31
P/B 1.24
P/C
EV/EBITDA -1.14
EV/Sales 0.31
Quick Ratio 1.31
Current Ratio 1.52
Debt/Eq 58.79
LT Debt/Eq
EPS (ttm) -1.04
EPS next Y -0.23
EPS Growth
Revenue Growth 36.20%
EPS Gr Q/Q
Rev Gr Q/Q
Earnings (next) 2026-05-14
Earnings (prior) 2026-03-19
ROA -28.00%
ROE -141.30%
ROIC
Gross Margin 73.71%
Oper. Margin 26.66%
Profit Margin -25.26%
Shs Outstand 11.65M
Shs Float 7.95M
Insider Own 14.12%
Instit Own 23.68%
Short Float 0.64%
Short Ratio 0.55
Short Interest 72.50K
52W High 1.19
vs 52W High -5.88%
52W Low 0.54
vs 52W Low 108.96%
Beta 0.64
Impl. Vol.
Rel Volume 0.31
Avg Volume 379.66K
Volume 119.34K
Target (mean) $6.00
Tgt Median $6.00
Tgt Low $3.00
Tgt High $9.00
# Analysts 2
Recom None
Prev Close $1.13
Price $1.12
Change -0.88%
About

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus Mean price target
2. Current target Latest analyst target
3. DCF / Fair value Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.12
Low
$3.00
High
$9.00
Mean
$6.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-05-19 main Benchmark Buy → Buy $3
2024-11-15 reit Benchmark Buy → Buy $7
2024-08-16 reit Benchmark Buy → Buy $7
2023-08-31 reit Benchmark Buy → Buy $18
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-05 LUEBBERT HERMANN Chief Executive Officer 137,500
2026-03-05 LEFFLER EUGENE FREDERICK Chief Financial Officer 87,500
2025-09-10 LUEBBERT HERMANN Chief Executive Officer 137,500
2025-09-10 LEFFLER EUGENE FREDERICK Chief Financial Officer 87,500
2024-05-17 LUEBBERT HERMANN Chief Executive Officer 4,771
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
41.70
+11.75%
37.32
+9.54%
34.07
+18.82%
28.67
Operating Revenue
41.70
+11.75%
37.32
+9.54%
34.07
+18.82%
28.67
Cost Of Revenue
10.96
-41.08%
18.61
+6.67%
17.44
+14.88%
15.19
Reconciled Cost Of Revenue
10.96
-41.08%
18.61
+6.67%
17.44
+14.88%
15.19
Gross Profit
30.74
+64.27%
18.71
+12.55%
16.63
+23.26%
13.49
Operating Expense
42.09
+17.16%
35.92
-8.37%
39.20
+9.29%
35.87
Research And Development
3.72
+78.03%
2.09
+2612.99%
0.08
0.00
Selling General And Administration
38.37
+13.40%
33.84
-13.53%
39.13
+9.08%
35.87
General And Administrative Expense
39.13
+9.08%
35.87
Other Gand A
39.13
+9.08%
35.87
Total Expenses
53.05
-2.71%
54.53
-3.74%
56.65
+10.95%
51.05
Operating Income
-11.35
+34.06%
-17.21
+23.77%
-22.58
-0.88%
-22.38
Total Operating Income As Reported
-11.35
+34.06%
-17.21
+24.11%
-22.68
-22.04%
-18.58
EBITDA
-9.19
+36.84%
-14.55
+21.13%
-18.45
-2075.70%
0.93
Normalized EBITDA
-10.09
+36.54%
-15.90
+25.95%
-21.48
-2.40%
-20.97
Reconciled Depreciation
0.87
-24.46%
1.15
+7.99%
1.06
-9.22%
1.17
EBIT
-10.06
+35.94%
-15.70
+19.55%
-19.52
-8100.42%
-0.24
Total Unusual Items
0.90
-33.26%
1.35
-55.34%
3.02
-86.20%
21.91
Total Unusual Items Excluding Goodwill
0.90
-33.26%
1.35
-55.34%
3.02
-86.20%
21.91
Special Income Charges
0.00
+100.00%
-0.32
-104.26%
7.42
+95.24%
3.80
Other Special Charges
0.32
+104.20%
-7.52
Restructuring And Mergern Acquisition
0.00
-100.00%
0.10
+102.63%
-3.80
Net Income
-10.54
+40.67%
-17.76
+11.78%
-20.13
-3045.47%
-0.64
Pretax Income
-10.51
+40.74%
-17.74
+11.83%
-20.12
-3208.72%
-0.61
Net Non Operating Interest Income Expense
-0.45
+77.79%
-2.04
-263.39%
-0.56
-175.86%
-0.20
Interest Expense Non Operating
0.45
-77.79%
2.04
+239.17%
0.60
+62.16%
0.37
Net Interest Income
-0.45
+77.79%
-2.04
-263.39%
-0.56
-175.86%
-0.20
Interest Expense
0.45
-77.79%
2.04
+239.17%
0.60
+62.16%
0.37
Interest Income Non Operating
0.07
-46.21%
0.13
-24.57%
0.17
Interest Income
0.07
-46.21%
0.13
-24.57%
0.17
Other Income Expense
1.29
-14.52%
1.51
-50.07%
3.02
-86.26%
21.98
Other Non Operating Income Expenses
0.39
+145.57%
0.16
+5366.67%
-0.00
-104.35%
0.07
Gain On Sale Of Security
0.90
-45.92%
1.67
+137.90%
-4.40
-124.28%
18.11
Tax Provision
0.03
+13.64%
0.02
+57.14%
0.01
-56.25%
0.03
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
0.19
-33.26%
0.28
-55.34%
0.63
-86.20%
4.60
Net Income Including Noncontrolling Interests
-10.54
+40.67%
-17.76
+11.78%
-20.13
-3045.47%
-0.64
Net Income From Continuing Operation Net Minority Interest
-10.54
+40.67%
-17.76
+11.78%
-20.13
-3045.47%
-0.64
Net Income From Continuing And Discontinued Operation
-10.54
+40.67%
-17.76
+11.78%
-20.13
-3045.47%
-0.64
Net Income Continuous Operations
-10.54
+40.67%
-17.76
+11.78%
-20.13
-3045.47%
-0.64
Normalized Income
-11.25
+40.25%
-18.83
+16.40%
-22.52
-25.48%
-17.95
Net Income Common Stockholders
-10.54
+40.67%
-17.76
+11.78%
-20.13
-3045.47%
-0.64
Diluted EPS
-3.22
+75.27%
-13.02
-2615.79%
-0.48
Basic EPS
-3.22
+75.27%
-13.02
-2615.79%
-0.48
Basic Average Shares
5.52
+256.74%
1.55
+15.83%
1.33
Diluted Average Shares
5.52
+256.74%
1.55
+15.83%
1.33
Diluted NI Availto Com Stockholders
-10.54
+40.67%
-17.76
+11.78%
-20.13
-3045.47%
-0.64
Total Other Finance Cost
0.04
-55.43%
0.09
+1050.00%
0.01
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
28.56
+29.24%
22.10
-20.88%
27.93
-45.11%
50.88
Current Assets
18.08
-12.64%
20.70
-10.29%
23.07
-46.51%
43.14
Cash Cash Equivalents And Short Term Investments
6.40
+8.27%
5.91
+316.05%
1.42
-94.88%
27.76
Cash And Cash Equivalents
6.39
+8.25%
5.91
+339.69%
1.34
-92.20%
17.21
Other Short Term Investments
0.01
+28.57%
0.01
-91.03%
0.08
-99.26%
10.55
Receivables
8.51
+58.40%
5.37
+4.07%
5.16
-30.30%
7.41
Accounts Receivable
7.29
+37.18%
5.32
+2.96%
5.16
+37.73%
3.75
Gross Accounts Receivable
7.39
+34.02%
5.51
+2.85%
5.36
+39.35%
3.85
Allowance For Doubtful Accounts Receivable
-0.10
+50.00%
-0.20
+0.00%
-0.20
-100.00%
-0.10
Other Receivables
Taxes Receivable
1.22
+2036.84%
0.06
Inventory
1.43
-78.54%
6.65
-39.07%
10.91
+52.18%
7.17
Prepaid Assets
0.55
+144.05%
0.23
-25.57%
0.30
-41.79%
0.52
Assets Held For Sale Current
0.00
-100.00%
2.30
0.00
Other Current Assets
1.19
+390.95%
0.24
-95.65%
5.58
+1852.45%
0.29
Total Non Current Assets
10.48
+648.11%
1.40
-71.16%
4.86
-37.28%
7.74
Net PPE
3.74
+280.67%
0.98
-43.70%
1.75
+10.58%
1.58
Gross PPE
4.01
+151.19%
1.60
-8.59%
1.75
-16.30%
2.09
Accumulated Depreciation
-0.27
+56.44%
-0.61
-10.05%
-0.56
-9.86%
-0.51
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
2.42
+646.15%
0.33
+0.62%
0.32
-5.83%
0.34
Other Properties
1.58
+75.42%
0.90
-48.28%
1.75
+26.98%
1.38
Leases
0.00
-100.00%
0.37
+0.00%
0.37
+0.00%
0.37
Goodwill And Other Intangible Assets
2.65
+7471.43%
0.04
-98.67%
2.63
-13.29%
3.03
Other Intangible Assets
2.65
+7471.43%
0.04
-98.67%
2.63
-13.29%
3.03
Non Current Accounts Receivable
2.81
Other Non Current Assets
4.09
+967.62%
0.38
-20.54%
0.48
+50.63%
0.32
Total Liabilities Net Minority Interest
18.08
+2.35%
17.67
-23.64%
23.14
-14.32%
27.01
Current Liabilities
11.89
-1.05%
12.02
-33.54%
18.09
-13.43%
20.89
Payables And Accrued Expenses
8.38
+0.08%
8.37
-20.04%
10.47
+3.18%
10.15
Payables
6.67
-7.42%
7.20
-20.05%
9.01
+247.72%
2.59
Accounts Payable
1.85
-0.05%
1.86
-43.89%
3.31
+158.84%
1.28
Current Accrued Expenses
1.72
+46.08%
1.17
-19.97%
1.47
-80.60%
7.56
Pensionand Other Post Retirement Benefit Plans Current
2.81
+15.53%
2.43
+11.12%
2.19
-23.33%
2.85
Current Debt And Capital Lease Obligation
0.33
-39.42%
0.55
-88.07%
4.59
+822.69%
0.50
Current Debt
3.90
Other Current Borrowings
3.90
Current Capital Lease Obligation
0.33
-39.42%
0.55
-20.69%
0.69
+38.76%
0.50
Current Deferred Liabilities
0.00
-100.00%
6.94
Current Deferred Revenue
0.00
-100.00%
6.94
Other Current Liabilities
0.32
-47.80%
0.61
-10.64%
0.69
+84.41%
0.37
Total Non Current Liabilities Net Minority Interest
6.19
+9.60%
5.65
+11.80%
5.05
-17.36%
6.11
Long Term Debt And Capital Lease Obligation
5.83
+33.26%
4.37
+444.03%
0.80
-5.19%
0.85
Long Term Debt
4.59
+11.98%
4.10
Long Term Capital Lease Obligation
1.24
+349.28%
0.28
-65.67%
0.80
-5.19%
0.85
Non Current Deferred Liabilities
0.00
-100.00%
2.40
Non Current Deferred Revenue
0.00
-100.00%
2.40
Other Non Current Liabilities
0.01
-60.87%
0.02
-37.84%
0.04
+76.19%
0.02
Stockholders Equity
10.48
+136.41%
4.43
-7.51%
4.79
-79.93%
23.88
Common Stock Equity
10.48
+136.41%
4.43
-7.51%
4.79
-79.93%
23.88
Capital Stock
0.01
+33.33%
0.01
+350.00%
0.00
+100.00%
0.00
Common Stock
0.01
+33.33%
0.01
+350.00%
0.00
+100.00%
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
11.65
+31.26%
8.87
+484.72%
1.52
+13.68%
1.33
Ordinary Shares Number
11.65
+31.26%
8.87
+484.72%
1.52
+13.68%
1.33
Additional Paid In Capital
138.41
+13.61%
121.83
+16.65%
104.44
+1.01%
103.40
Retained Earnings
-127.94
-8.97%
-117.41
-17.82%
-99.65
-25.32%
-79.52
Total Equity Gross Minority Interest
10.48
+136.41%
4.43
-7.51%
4.79
-79.93%
23.88
Total Capitalization
15.07
+76.64%
8.53
+77.99%
4.79
-79.93%
23.88
Working Capital
6.19
-28.70%
8.68
+74.03%
4.99
-77.58%
22.25
Invested Capital
15.07
+76.64%
8.53
-1.91%
8.70
-63.58%
23.88
Total Debt
6.16
+25.17%
4.92
-8.83%
5.40
+301.11%
1.35
Net Debt
2.56
Capital Lease Obligations
1.57
+90.78%
0.82
-44.88%
1.50
+11.07%
1.35
Net Tangible Assets
7.83
+78.04%
4.40
+103.23%
2.16
-89.62%
20.85
Tangible Book Value
7.83
+78.04%
4.40
+103.23%
2.16
-89.62%
20.85
Current Provisions
0.06
-1.72%
0.06
-61.07%
0.15
+81.71%
0.08
Derivative Product Liabilities
0.35
-71.92%
1.25
-70.31%
4.21
+48.08%
2.84
Duefrom Related Parties Current
0.00
-100.00%
3.66
Duefrom Related Parties Non Current
0.00
-100.00%
2.81
Dueto Related Parties Current
4.81
-9.97%
5.34
-6.21%
5.70
+334.30%
1.31
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-13.36
-30.10%
-10.27
+58.75%
-24.89
-53.68%
-16.20
Cash Flow From Continuing Operating Activities
-13.36
-30.10%
-10.27
+58.75%
-24.89
-53.68%
-16.20
Net Income From Continuing Operations
-10.54
+40.67%
-17.76
+11.78%
-20.13
-3045.47%
-0.64
Depreciation Amortization Depletion
0.87
-24.46%
1.15
+7.99%
1.06
-9.22%
1.17
Depreciation
0.87
-24.46%
1.15
+77.86%
0.65
-14.32%
0.75
Amortization Cash Flow
0.33
-21.29%
0.42
+0.00%
0.42
Depreciation And Amortization
0.87
-24.46%
1.15
+7.99%
1.06
-9.22%
1.17
Amortization Of Intangibles
0.33
-21.29%
0.42
+0.00%
0.42
Other Non Cash Items
0.51
+71.72%
0.30
+104.31%
-6.88
-99.97%
-3.44
Stock Based Compensation
0.95
-6.67%
1.02
-2.49%
1.04
-43.57%
1.85
Provisionand Write Offof Assets
-0.07
-142.59%
0.16
+32.79%
0.12
-40.78%
0.21
Operating Gains Losses
-1.60
-18.59%
-1.35
-131.53%
4.28
+126.13%
-16.39
Gain Loss On Investment Securities
-0.90
+45.92%
-1.67
-138.91%
4.28
+126.13%
-16.39
Unrealized Gain Loss On Investment Securities
7.42
+524.79%
-1.75
Gain Loss On Sale Of PPE
-0.70
0.00
Change In Working Capital
-3.48
-156.08%
6.21
+241.37%
-4.39
-257.60%
2.79
Change In Receivables
-1.91
-509.27%
-0.31
-106.34%
4.93
+0.28%
4.92
Changes In Account Receivables
-1.91
-505.40%
-0.32
+79.49%
-1.54
-2094.29%
-0.07
Change In Inventory
1.45
-65.86%
4.23
+212.88%
-3.75
-33.45%
-2.81
Change In Prepaid Assets
-1.73
-1125.53%
-0.14
-181.03%
0.17
-95.81%
4.15
Change In Payables And Accrued Expense
0.07
+103.68%
-2.04
-3282.81%
0.06
+102.37%
-2.69
Change In Accrued Expense
0.61
+365.22%
-0.23
+96.38%
-6.35
-76.07%
-3.61
Change In Payable
-0.54
+70.39%
-1.81
-128.17%
6.42
+603.40%
0.91
Change In Account Payable
-0.54
+70.39%
-1.81
-128.17%
6.42
Change In Other Current Assets
-0.69
-113.30%
5.16
+200.00%
-5.16
0.00
Change In Other Current Liabilities
-0.68
+0.87%
-0.69
-4.87%
-0.66
+15.88%
-0.78
Investing Cash Flow
3.00
+100033.33%
-0.00
-100.48%
0.62
+112.01%
-5.16
Cash Flow From Continuing Investing Activities
3.00
+100033.33%
-0.00
-100.48%
0.62
+112.01%
-5.16
Net PPE Purchase And Sale
-0.00
+80.00%
-0.01
-100.00%
-0.01
+86.84%
-0.04
Purchase Of PPE
-0.00
+80.00%
-0.01
-100.00%
-0.01
+86.84%
-0.04
Capital Expenditure
-0.00
+96.67%
-0.06
-1100.00%
-0.01
+86.84%
-0.04
Net Investment Purchase And Sale
0.00
-100.00%
0.06
-90.87%
0.62
+112.19%
-5.12
Purchase Of Investment
0.00
+100.00%
-5.12
Sale Of Investment
0.00
-100.00%
0.06
-90.87%
0.62
0.00
Net Intangibles Purchase And Sale
0.00
+100.00%
-0.05
0.00
Purchase Of Intangibles
0.00
+100.00%
-0.05
0.00
Net Other Investing Changes
3.00
Financing Cash Flow
10.85
-26.86%
14.84
+76.38%
8.41
-40.01%
14.02
Cash Flow From Continuing Financing Activities
10.85
-26.86%
14.84
+76.38%
8.41
-40.01%
14.02
Net Issuance Payments Of Debt
0.00
+100.00%
-0.27
-106.79%
3.90
0.00
Issuance Of Debt
4.05
-83.96%
25.25
0.00
Repayment Of Debt
0.00
+100.00%
-4.32
+79.78%
-21.34
Long Term Debt Issuance
21.45
0.00
Net Long Term Debt Issuance
21.45
0.00
Short Term Debt Issuance
4.05
-83.96%
25.25
0.00
Short Term Debt Payments
0.00
+100.00%
-4.32
+79.78%
-21.34
Net Short Term Debt Issuance
0.00
+100.00%
-0.27
-106.79%
3.90
0.00
Net Common Stock Issuance
0.00
-100.00%
4.51
-52.01%
9.39
Proceeds From Stock Option Exercised
0.00
-100.00%
7.44
0.00
-100.00%
4.63
Changes In Cash
0.49
-89.32%
4.56
+128.76%
-15.87
-116.32%
-7.33
Beginning Cash Position
6.11
+295.66%
1.54
-91.14%
17.41
-29.64%
24.74
End Cash Position
6.59
+7.98%
6.11
+295.66%
1.54
-91.14%
17.41
Free Cash Flow
-13.36
-29.36%
-10.33
+58.51%
-24.90
-53.35%
-16.24
Interest Paid Supplemental Data
0.01
-99.65%
1.73
+1075.51%
0.15
+14600.00%
0.00
Income Tax Paid Supplemental Data
0.03
+4.17%
0.02
+60.00%
0.01
-53.13%
0.03
Common Stock Issuance
0.00
-100.00%
4.51
-52.01%
9.39
Issuance Of Capital Stock
10.85
+41.61%
7.66
+70.00%
4.51
-52.01%
9.39
Net Preferred Stock Issuance
10.85
+41.61%
7.66
0.00
Preferred Stock Issuance
10.85
+41.61%
7.66
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category